Fortitude Mining has acquired a 9.4% stake in HeartSciences for nearly $1 million, injecting cash into the Nasdaq-listed company as both sides await a critical shareholder vote on their proposed merger
Fortitude Mining, a Zcash-focused mining company backed by Digital Currency Group, has purchased a 9.4% equity stake in HeartSciences, a Nasdaq-listed firm, for just under $1 million. The deal, structured as a private placement, comes as HeartSciences faces a pivotal shareholder vote on a proposed merger with Fortitude. The investment provides HeartSciences with immediate operating capital but does not alter the terms of the merger agreement or the exchange ratio for existing equity holders.
Deal Structure and Timing
The private placement, completed on August 12, involved Fortitude Mining acquiring 411,522 common shares of HeartSciences at $2.43 per share, totaling $999,998.46. According to HeartSciences, this price represented a 22% premium over the company's closing share price on the day of the transaction. The funds are earmarked for operating expenses as HeartSciences continues to navigate the merger process. Importantly, the cash infusion is structured as an equity purchase rather than a loan, meaning Fortitude now holds a direct stake in HeartSciences but will not receive additional merger consideration for this investment.
Merger Uncertainty and Liquidation Risk
The merger, if approved, would result in Digital Currency Group controlling approximately 95% of the combined company's voting interests, with existing HeartSciences shareholders retaining about 5%, subject to final capitalization and exchange-ratio adjustments. The companies have targeted the second half of 2026 for closing, but the timeline remains tentative. HeartSciences' preliminary proxy materials, as of August 20, still lacked a definitive date for the shareholder vote, and the company has warned that failure to complete the merger could leave it with limited options. If no alternative transaction emerges, HeartSciences may be forced to liquidate, with no guarantee that shareholders would recover any remaining cash.
Financial Performance and Market Context
Fortitude Mining reported $8.5 million in adjusted EBITDA, a non-GAAP measure, but posted a $9.5 million net loss under GAAP, driven in part by a $10.3 million impairment on mining equipment. The company's financials highlight the volatility and capital intensity of crypto mining operations. HeartSciences, meanwhile, is using the new capital to maintain operations while awaiting the outcome of the merger vote. The situation echoes broader challenges faced by Nasdaq-listed crypto and blockchain companies, such as those described in EgonCoin's coverage of Greenlane's struggle with altcoin treasury losses and delisting risk.
Next Steps for Shareholders
For HeartSciences shareholders, the next major development will be the release of a definitive proxy statement that sets the date for the special meeting and vote. Until then, Fortitude's equity investment provides a temporary financial buffer but does not eliminate the risk that the merger could fail or that HeartSciences could face liquidation if no alternative emerges. The outcome will determine whether HeartSciences continues as part of a larger crypto mining entity or is forced to wind down operations.
Equity placements like this one highlight the complex interplay between capital needs, merger negotiations, and shareholder risk in the crypto sector. When a merger is pending, new investments can provide critical runway but may not guarantee a favorable outcome for existing investors. The structure of such deals-whether as loans, equity, or convertible instruments-can have significant implications for dilution, voting power, and the ultimate fate of the company if the transaction does not close as planned.
